Verition Fund Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Sell
1,200
-25,100
-95% -$12.6M ﹤0.01% 1542
2025
Q4
$12.3M Buy
26,300
+6,100
+30% +$2.83M 0.05% 369
2025
Q3
$8.61M Buy
20,200
+600
+3% +$233K 0.04% 631
2025
Q2
$7.51M Buy
19,600
+16,200
+476% +$5.84M 0.03% 720
2025
Q1
$1.17M Sell
3,400
-12,600
-79% -$4.05M 0.01% 2001
2024
Q4
$4.8M Sell
16,000
-9,400
-37% -$3.29M 0.02% 911
2024
Q3
$10.3M Buy
25,400
+1,600
+7% +$586K 0.05% 390
2024
Q2
$7.65M Buy
23,800
+2,500
+12% +$812K 0.04% 490
2024
Q1
$7.1M Buy
21,300
+17,600
+476% +$5.38M 0.05% 476
2023
Q4
$1M Hold
3,700
0.01% 1185
2023
Q3
$910K Buy
+3,700
New +$1.01M 0.01% 1129
2022
Q2
Sell
-14,900
Closed -$3.73M 2644
2022
Q1
$3.73M Buy
14,900
+2,500
+20% +$628K 0.04% 543
2021
Q4
$3.19M Buy
+12,400
New +$3.03M 0.02% 585

Other funds holding HCA

Verition Fund Management's HCA Position: Q1 2026 in Review

Verition Fund Management reduced its HCA Healthcare (HCA) stake by 98% in Q1 2026, selling an estimated $10M and leaving 451 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Verition Fund Management first reported a position in HCA in Q2 2013 and has held it in 35 quarters since. The position peaked at $9.49M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Verition Fund Management held 451 shares of HCA Healthcare worth $213K as of Q1 2026.
  • Verition Fund Management sold 19,872 HCA Healthcare shares in Q1 2026, an estimated $10M.
  • HCA Healthcare made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1931 holding.
  • Verition Fund Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 35 quarters since.
  • Verition Fund Management's HCA Healthcare position peaked at $9.49M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.